“The Future of Pharma & MedTech: A Digital-First Approach” report, released by FINN Partners at Arab Health 2025 in Dubai, highlights how Pharma & MedTech companies are winning in a data-driven era.
Middle East, 5 February 2025 – The Middle East is leading a health revolution, with digital innovation at its core, as revealed in the latest report “The Future of Pharma & MedTech: A Digital-First Approach”. The report was released by FINN Partners, a global leader in marketing and communications, at Arab Health 2025 in Dubai. The report highlights that the digital-first approach is redefining the health sector in the UAE and Saudi Arabia by transforming operations, customer experiences, and business models. By analysing digital usage patterns, Pharma and MedTech companies can create data-driven strategies, enhancing accessibility, compliance, and engagement, while fostering agility and scalability to meet growing health demands seamlessly.
The new research explored the success of digital communications strategies by some of the most significant Pharma and MedTech companies operating in the Middle East, assessing the scale and impact of their owned social posts over the past year (both global channels posting about Middle Eastern topics and specific Middle Eastern handles). The insights showed:
- More content does not guarantee higher engagement—audiences respond to relevance, not just volume.
- Localisation, targeting, and cultural relevance are essential for meaningful audience connections.
- Educational value and emotional resonance are powerful drivers of trust and engagement.
“With a young, tech-savvy population and forward-thinking government policies, the UAE and Saudi Arabia are perfectly positioned to lead the global charge in digital health. By focusing on sustainable growth, strict regulatory compliance, and building collaborative ecosystems, the region is setting new benchmarks in innovation, efficiency, and resilience for the Pharma and MedTech sectors,” said Aman Gupta, Managing Partner at SPAG FINN Partners.
The report also provides actionable recommendations for companies to excel in the evolving Middle Eastern landscape. It emphasises adopting patient-centric solutions by leveraging digital storytelling to humanise brands and create emotional connections. Furthermore, the importance of prioritising localised strategies is highlighted, urging businesses to align their efforts with cultural sensitivities and regulatory frameworks to ensure greater market relevance and impact.
“Harnessing the power of social media, alongside other channels, is absolutely essential for success in the Middle East’s evolving health landscape, allowing health companies to craft targeted campaigns that enhance visibility, build trust and drive meaningful engagement among regional audiences. At the same time, companies need to prioritise localised strategies that reflect the nuances and unique dynamics of the region. It’s this blend of cutting-edge digital tools and culturally aligned approaches that enables businesses not just to navigate the Middle East’s rapidly transforming health sector, but to take the lead in shaping its future,” said Thomas Morris, UAE lead, FINN Partners.
“The Middle East is rapidly emerging as a global leader in health innovation, and companies in the Pharma and MedTech sectors must adapt to this dynamic landscape to thrive. By placing the patient at the heart of their strategies, businesses can build trust and loyalty in an increasingly competitive market,” said Gil Bashe, Chair Global Health and Purpose at FINN Partners.
With unparalleled growth opportunities, the Middle East stands at the forefront of a global health transformation. This report serves as both a roadmap and a rallying cry for Pharma and MedTech leaders to reimagine the future of health in a digital-first era.
FINN Partners has established a strong presence in the Middle East, leveraging its global expertise to support brands in the region. With a keen understanding of both international trends and local dynamics, the agency helps businesses navigate the Middle Eastern market. By offering a blend of regional knowledge and global insights, FINN Partners empowers brands with a tailored approach to expand their reach, enhance their visibility, and drive growth, ensuring that they stay competitive and responsive to the needs of consumers across the region.
The Middle East is at the forefront of digital health innovation. Download the report to discover how Pharma and MedTech companies can excel in this dynamic landscape.
___________________________________________________________________________
About FINN Partners
Founded in 2011 on the core principles of innovation and collaborative partnership, FINN Partners has grown from about $24 million in fees to almost $170 million in fees over ten years, becoming one of the fastest growing independent public relations agencies in the world. The full-service marketing and communications company’s record setting pace is a result of organic growth and integrating new companies and new people into the FINN world through a common philosophy. With more than 1,500 professionals across 34 offices, FINN provides clients with global access and capabilities in the Americas, Europe, Middle East and Asia. FINN Partners clients are also supported through longstanding partner agencies and its membership in the PROI network of leading agencies around the world. Headquartered in New York, FINN has offices in: Abu Dhabi, Atlanta, Bangalore, Beijing, Boston, Chicago, Delhi, Denver, Detroit, Dublin, Fort Lauderdale, Frankfurt, Guam, Hong Kong, Honolulu, Jerusalem, Kuala Lumpur, London, Los Angeles, Manila, Mumbai, Munich, Nashville, Orange County, Paris, Portland, San Diego, San Francisco, Seattle, Shanghai, Singapore, Vancouver and Washington D.C.
Find us at finnpartners.com and follow us on X and Instagram at @finnpartners.